BlackRock Advisors LLC Has $33,213,000 Position in BioMarin Pharmaceutical Inc. (BMRN)
Biomirin | December 14, 2016
BlackRock Advisors LLC reduced its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 98.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 358,973 shares of the company’s stock after selling 27,783,688 shares during the period. BlackRock Advisors LLC owned about 0.21% of BioMarin Pharmaceutical worth $33,213,000 at the end of the most recent quarter.